Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin for prevention of breast cancer recurrence
IRCT201202218215N1Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Mar 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of aspirin in breast cancer, sponsored by Shiraz University of Medical Sciences. Started Mar 2012; status: completed.
02
Drugs
aspirin
03
Conditions
breast cancer
Beyond the preview
Go deeper on IRCT201202218215N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201202218215N1.